- Home
- PRCH vs PRME Comparison
PRCH vs PRME Comparison
Compare PRCH & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRCH | PRME |
|---|---|---|
| Founded | 2012 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 753.7M | 666.1M |
| IPO Year | 2019 | 2022 |
Fundamental Metrics
Financial Performance| Metric | PRCH | PRME |
|---|---|---|
| Price | $7.07 | $3.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $18.00 | $7.56 |
| AVG Volume (30 Days) | 1.1M | ★ 2.1M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.91 | 18.18 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $482,414,000.00 | $4,632,000.00 |
| Revenue This Year | $3.89 | $12.41 |
| Revenue Next Year | $16.80 | $52.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 10.18 | ★ 55.28 |
| 52 Week Low | $4.65 | $1.11 |
| 52 Week High | $19.44 | $6.94 |
Technical Indicators
Market Signals| Indicator | PRCH | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 44.35 | 54.29 |
| Support Level | $6.54 | $3.17 |
| Resistance Level | $8.29 | $3.94 |
| Average True Range (ATR) | 0.42 | 0.26 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 32.97 | 82.53 |
Price Performance
Historical ComparisonAbout PRCH Porch Group Inc.
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has four reportable segments: Insurance Services, Software & Data, Consumer Services, and Corporate. The majority of revenue is from the Insurance segment. The Insurance Services segment manages and operates the Reciprocal, providing services related, but not limited, to underwriting, policy renewal, risk management, insurance portfolio management, financial management, and setting investment guidelines in exchange for commissions and fees.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.